Orbcel-C ( DrugBank: Orbcel-C )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
94	原発性硬化性胆管炎	1
95	自己免疫性肝炎	1

94. 原発性硬化性胆管炎

臨床試験数 : 148 / 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02997878 (ClinicalTrials.gov)	December 7, 2018	13/12/2016	Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH	An Adaptive, Multicentre, Phase IIa, Multi-disease Trial Investigating the Safety & Activity of a Si ...	Cholangitis, Sclerosing;Hepatitis, Autoimmune	Biological: Orbcel-C	University of Birmingham	NHS Blood and Transplant	Recruiting	18 Years	N/A	All	18	Phase 1/Phase 2	United Kingdom

臨床試験数 : 52 / 薬物数 : 68 - (DrugBank : 27) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 111

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02997878 (ClinicalTrials.gov)	December 7, 2018	13/12/2016	Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH	An Adaptive, Multicentre, Phase IIa, Multi-disease Trial Investigating the Safety & Activity of a Si ...	Cholangitis, Sclerosing;Hepatitis, Autoimmune	Biological: Orbcel-C	University of Birmingham	NHS Blood and Transplant	Recruiting	18 Years	N/A	All	18	Phase 1/Phase 2	United Kingdom